Intelerad announces expansion of cloud-based imaging solution suite

Published on:

Intelerad Medical Systems ™, based in Montreal, Canada, has announced today the expansion of its cloud-based solution suite that now offers a complete cloud-based imaging platform to the medical imaging community, according to an Intelerad press release.  

A leader in diagnostic views and collaboration solutions for hospitals and imaging centers, Intelerad's latest expansion includes "an Imaging Infastructure-as-a-Service (IaaS)".  

The company's newest innovative platform will allow Intelerad clients to offload IT management and will be fully in charge of managing services, specifically in designing and maintaining on-site hardware, storage infrastructure, and overall security.  

“With this latest offering, we are truly taking our cloud imaging platform to the next level - going beyond cloud-based storage and disaster recovery solutions to provide fully-hosted infrastructure and associated services,” said Christian Bazinet, Chief Operating Officer of Intelerad, in a statement. “In addition, we are expanding the availability of our managed services beyond U.S. borders, into all the regions we currently serve.”  

See the official press release here.   

Related Content

Top performing PACS companies based on user feedback
Key trends in enterprise imaging
Aycan introduces a 'mini' PACS for independent practices
OmegaAI adds 'progressive loading' for real-time radiology image reading
Philips moves digital pathology to the cloud with AWS
Best in KLAS 2024 rankings released, showcasing medical imaging IT systems

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.